Literature DB >> 23663386

The clinical relevance of attentional bias in substance use disorders.

Matt Field1, Reshmi Marhe2, Ingmar H A Franken2.   

Abstract

Individuals with substance use disorders typically show an "attentional bias" for substance-related cues: Those cues are able to grab and hold the attention, in preference to other cues in the environment. We discuss the theoretical context for this work before reviewing the measurement of attentional bias, and its relationship to motivational state and relapse to substance use after a period of abstinence. Finally, we discuss the implications of this research for the treatment of substance use disorders. We conclude that attentional bias is associated with subjective craving, and that moment-by-moment fluctuations in attentional bias may precede relapse to substance use. The evidence regarding the predictive relationship between attentional bias assessed in treatment contexts and subsequent relapse is inconsistent. Furthermore, there is currently insufficient evidence to endorse attentional bias modification as a treatment for substance use disorders. Clinical implications and suggestions for future research are highlighted.

Entities:  

Mesh:

Year:  2013        PMID: 23663386     DOI: 10.1017/S1092852913000321

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  54 in total

1.  Neural Correlates of Drug-Biased Choice in Currently Using and Abstinent Individuals With Cocaine Use Disorder.

Authors:  Scott J Moeller; Anna Zilverstand; Anna B Konova; Prantik Kundu; Muhammad A Parvaz; Rebecca Preston-Campbell; Keren Bachi; Nelly Alia-Klein; Rita Z Goldstein
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-11-11

2.  N-Acetylcysteine reduces cocaine-cue attentional bias and differentially alters cocaine self-administration based on dosing order.

Authors:  B Levi Bolin; Joseph L Alcorn; Joshua A Lile; Craig R Rush; Abner O Rayapati; Lon R Hays; William W Stoops
Journal:  Drug Alcohol Depend       Date:  2017-06-29       Impact factor: 4.492

Review 3.  At the crossroads: the intersection of substance use disorders, anxiety disorders, and posttraumatic stress disorder.

Authors:  Lesia M Ruglass; Teresa Lopez-Castro; Soumia Cheref; Santiago Papini; Denise A Hien
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

4.  Drug Stroop: Mechanisms of response to computerized cognitive behavioral therapy for cocaine dependence in a randomized clinical trial.

Authors:  Elise E DeVito; Brian D Kiluk; Charla Nich; Maria Mouratidis; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2017-12-07       Impact factor: 4.492

Review 5.  Evidence for incentive salience sensitization as a pathway to alcohol use disorder.

Authors:  Roberto U Cofresí; Bruce D Bartholow; Thomas M Piasecki
Journal:  Neurosci Biobehav Rev       Date:  2019-10-28       Impact factor: 8.989

6.  Dissociable Components of Experience-Driven Attention.

Authors:  Haena Kim; Brian A Anderson
Journal:  Curr Biol       Date:  2019-02-14       Impact factor: 10.834

7.  On the relationship between value-driven and stimulus-driven attentional capture.

Authors:  Brian A Anderson; Haena Kim
Journal:  Atten Percept Psychophys       Date:  2019-04       Impact factor: 2.199

8.  Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats.

Authors:  Harshini Neelakantan; Erica D Holliday; Robert G Fox; Sonja J Stutz; Sandra D Comer; Margaret Haney; Noelle C Anastasio; F Gerard Moeller; Kathryn A Cunningham
Journal:  ACS Chem Neurosci       Date:  2017-02-13       Impact factor: 4.418

Review 9.  Theoretical implications and clinical support for heart rate variability biofeedback for substance use disorders.

Authors:  Teresa M Leyro; Jennifer F Buckman; Marsha E Bates
Journal:  Curr Opin Psychol       Date:  2019-04-02

Review 10.  What is abnormal about addiction-related attentional biases?

Authors:  Brian A Anderson
Journal:  Drug Alcohol Depend       Date:  2016-08-03       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.